Table 3 Least squares mean change in patient-reported outcomes within each group
Study Period | Baseline to Week 6 | Week 6 to Week 12 | ||||||
|---|---|---|---|---|---|---|---|---|
Incremental HD | Conventional HD | Incremental HD | Conventional HD | |||||
LS mean change (SE) | P value | LS mean change (SE) | P value | LS mean change (SE) | P value | LS mean change (SE) | P value | |
Model 1 | ||||||||
 DSI | −10.3 (4.7) | 0.03 | −14.0 (4.8) | 0.005 | −3.3 (3.2) | 0.30 | −2.7 (3.2) | 0.40 |
 GAD-7 | −2.0 (1.0) | 0.03 | −0.2 (1.0) | 0.89 | 0.5 (0.7) | 0.25 | −0.5 (0.7) | 0.60 |
 PHQ-9 | −2.5 (1.1) | 0.04 | −2.8 (1.1) | 0.01 | 0.3 (0.6) | 0.70 | −0.6 (0.6) | 0.34 |
Model 2 | ||||||||
 DSI | −9.7 (4.8) | 0.05 | −13.8 (5.0) | 0.009 | −3.1 (3.2) | 0.34 | −2.4 (5.5) | 0.67 |
 GAD-7 | −1.9 (1.0) | 0.07 | −1.5 (1.4) | 0.31 | 0.5 (0.6) | 0.46 | 0.1 (0.6) | 0.87 |
 PHQ-9 | −2.5 (1.1) | 0.03 | −3.5 (1.5) | 0.02 | −0.3 (0.6) | 0.70 | −0.5 (0.6) | 0.47 |